Benzinga Bulls and Bears: GameStop, Marvell, Robinhood
Benzinga examined the prospects for many investors’ favorite stocks over the last week — here’s a look at some of our top stories.
Stocks · News reference
Wealthfront, Orchestra Biomed, AeroVironment And Other Big Stocks Moving Higher On Thursday
U.S. stocks fell, but Wealthfront surged 6.6% after beating Q2 earnings and revenue estimates; Orchestra Biomed, Clover Health and AeroVironment also rose.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
S&P 500 Snaps 4-Day Decline as Oil Cools, Dell Jumps 11%: Stock Market Today
Equities rebounded Friday as crude retreated from $100, though hot CPI pushed Fed hike odds to 90%. Dell jumped 11%on Oracle's capex plan.
AeroVironment Stock Drops, B of A Maintains Buy Rating
AeroVironment shares are falling after B of A Securities maintained its Buy rating on the stock but cut its price target to $185 from $225.
AeroVironment shares are trading lower. B of A Securities maintained its Buy rating on the stock and lowered its price target from $225 to $185.
8-K filing — CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)
Filed: 2026-08-20 AccNo: 0001801170-26-000214 Size: 2 MB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
UBS Maintains Neutral on Clover Health Investments, Raises Price Target to $5
UBS analyst Jonathan Yong maintains Clover Health Investments (NASDAQ:CLOV) with a Neutral and raises the price target from $4.75 to $5.